Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 210

1.

Exercise decreases anti-müllerian hormone in anovulatory overweight women with polycystic ovary syndrome: a pilot study.

Moran LJ, Harrison CL, Hutchison SK, Stepto NK, Strauss BJ, Teede HJ.

Horm Metab Res. 2011 Dec;43(13):977-9. doi: 10.1055/s-0031-1291208. Epub 2011 Oct 11.

PMID:
21989557
2.

Is the plasma anti-Müllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome?

Skałba P, Cygal A, Madej P, Dąbkowska-Huć A, Sikora J, Martirosian G, Romanik M, Olszanecka-Glinianowicz M.

Eur J Obstet Gynecol Reprod Biol. 2011 Oct;158(2):254-9. doi: 10.1016/j.ejogrb.2011.06.006. Epub 2011 Jul 12.

PMID:
21752527
3.

Serum antimüllerian hormone in response to dietary management and/or physical exercise in overweight/obese women with polycystic ovary syndrome: secondary analysis of a randomized controlled trial.

Nybacka Å, Carlström K, Fabri F, Hellström PM, Hirschberg AL.

Fertil Steril. 2013 Oct;100(4):1096-102. doi: 10.1016/j.fertnstert.2013.06.030. Epub 2013 Jul 19.

PMID:
23876536
4.

Diet, physical exercise and Orlistat administration increase serum anti-Müllerian hormone (AMH) levels in women with polycystic ovary syndrome (PCOS).

Vosnakis C, Georgopoulos NA, Rousso D, Mavromatidis G, Katsikis I, Roupas ND, Mamali I, Panidis D.

Gynecol Endocrinol. 2013 Mar;29(3):242-5. doi: 10.3109/09513590.2012.736557. Epub 2012 Nov 30.

PMID:
23194076
5.

The impact of intensified exercise training on insulin resistance and fitness in overweight and obese women with and without polycystic ovary syndrome.

Harrison CL, Stepto NK, Hutchison SK, Teede HJ.

Clin Endocrinol (Oxf). 2012 Mar;76(3):351-7. doi: 10.1111/j.1365-2265.2011.04160.x.

PMID:
21711376
6.

Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome.

Pierre A, Peigné M, Grynberg M, Arouche N, Taieb J, Hesters L, Gonzalès J, Picard JY, Dewailly D, Fanchin R, Catteau-Jonard S, di Clemente N.

Hum Reprod. 2013 Mar;28(3):762-9. doi: 10.1093/humrep/des460. Epub 2013 Jan 14.

PMID:
23321213
7.

Polycystic ovary syndrome and anti-Müllerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins.

Cassar S, Teede HJ, Moran LJ, Joham AE, Harrison CL, Strauss BJ, Stepto NK.

Clin Endocrinol (Oxf). 2014 Dec;81(6):899-906. doi: 10.1111/cen.12557. Epub 2014 Sep 1.

PMID:
25040369
8.

The effect of weight loss on anti-Müllerian hormone levels in overweight and obese women with polycystic ovary syndrome and reproductive impairment.

Thomson RL, Buckley JD, Moran LJ, Noakes M, Clifton PM, Norman RJ, Brinkworth GD.

Hum Reprod. 2009 Aug;24(8):1976-81. doi: 10.1093/humrep/dep101. Epub 2009 Apr 20.

PMID:
19380385
9.

Anti-Müllerian hormone in women with polycystic ovary syndrome before and after therapy with metformin.

Tomova A, Deepinder F, Robeva R, Kirilov G, Mechandjiev Z, Kumanov P.

Horm Metab Res. 2011 Sep;43(10):723-7. doi: 10.1055/s-0031-1286307. Epub 2011 Sep 19.

PMID:
21932178
10.

The use of anti-mullerian hormone in predicting menstrual response after weight loss in overweight women with polycystic ovary syndrome.

Moran LJ, Noakes M, Clifton PM, Norman RJ.

J Clin Endocrinol Metab. 2007 Oct;92(10):3796-802. Epub 2007 Jul 24.

PMID:
17652213
11.

The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome.

Nardo LG, Yates AP, Roberts SA, Pemberton P, Laing I.

Hum Reprod. 2009 Nov;24(11):2917-23. doi: 10.1093/humrep/dep225. Epub 2009 Jul 18.

PMID:
19617605
12.

The value of measuring anti-Mullerian hormone in women with anovulatory polycystic ovary syndrome undergoing laparoscopic ovarian diathermy.

Amer SA, Li TC, Ledger WL.

Hum Reprod. 2009 Nov;24(11):2760-6. doi: 10.1093/humrep/dep271. Epub 2009 Jul 29.

PMID:
19640893
13.

Clinical significance of serum concentration of anti-Müllerian hormone in obese women with polycystic ovary syndrome.

El-Halawaty S, Rizk A, Kamal M, Aboulhassan M, Al-Sawah H, Noah O, Al-Inany H.

Reprod Biomed Online. 2007 Nov;15(5):495-9.

PMID:
18028738
14.

Anti-Mullerian hormone is increased in follicular fluid from unstimulated ovaries in women with polycystic ovary syndrome.

Das M, Gillott DJ, Saridogan E, Djahanbakhch O.

Hum Reprod. 2008 Sep;23(9):2122-6. doi: 10.1093/humrep/den185. Epub 2008 Jun 10.

PMID:
18550512
15.

Randomized comparison of the influence of dietary management and/or physical exercise on ovarian function and metabolic parameters in overweight women with polycystic ovary syndrome.

Nybacka Å, Carlström K, Ståhle A, Nyrén S, Hellström PM, Hirschberg AL.

Fertil Steril. 2011 Dec;96(6):1508-13. doi: 10.1016/j.fertnstert.2011.09.006. Epub 2011 Sep 29.

PMID:
21962963
16.

Structured exercise training programme versus hypocaloric hyperproteic diet in obese polycystic ovary syndrome patients with anovulatory infertility: a 24-week pilot study.

Palomba S, Giallauria F, Falbo A, Russo T, Oppedisano R, Tolino A, Colao A, Vigorito C, Zullo F, Orio F.

Hum Reprod. 2008 Mar;23(3):642-50. Epub 2007 Dec 23.

PMID:
18158291
18.

Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.

Piltonen T, Morin-Papunen L, Koivunen R, Perheentupa A, Ruokonen A, Tapanainen JS.

Hum Reprod. 2005 Jul;20(7):1820-6. Epub 2005 Mar 31.

PMID:
15802325
19.

Sibutramine administration decreases serum anti-Müllerian hormone (AMH) levels in women with polycystic ovary syndrome.

Vosnakis C, Georgopoulos NA, Armeni AK, Papadakis E, Roupas ND, Katsikis I, Panidis D.

Eur J Obstet Gynecol Reprod Biol. 2012 Aug;163(2):185-9. doi: 10.1016/j.ejogrb.2012.04.014. Epub 2012 May 11.

PMID:
22579228
20.

Serum anti-Müllerian hormone and ovarian morphology assessed by magnetic resonance imaging in response to acupuncture and exercise in women with polycystic ovary syndrome: secondary analyses of a randomized controlled trial.

Leonhardt H, Hellström M, Gull B, Lind AK, Nilsson L, Janson PO, Stener-Victorin E.

Acta Obstet Gynecol Scand. 2015 Mar;94(3):279-87. doi: 10.1111/aogs.12571. Epub 2015 Jan 28.

PMID:
25545309

Supplemental Content

Support Center